Max Bayer – Page 4 – Endpoints News

about the author

Max Bayer

Pharma Reporter

mbayer@endpointsnews.com

author articles

Updated: Moderna reports $238M manufacturing write-down as cuts, new vaccines shape 2025

3 months ago

Novo's weight loss drug helps curb some drinking habits, small study shows

3 months ago

SpringWorks lands FDA approval for nerve tumor treatment

3 months ago

Merck KGaA confirms interest in acquiring cancer biotech SpringWorks

3 months ago

AbbVie wins FDA approval for new antibiotic to treat complex intra-abdominal infections

3 months ago

Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out

3 months ago

Bristol Myers prunes pipeline amid new round of cost cuts

3 months ago

Pfizer says it has at least $10B available for deals in 2025, with a focus on pipeline

3 months ago

Updated: RFK Jr. advances out of Senate committee with Cassidy’s support

3 months ago

Updated: Pfizer sticks to 2025 projections as Covid sales stabilize, R&D revamp continues

3 months ago

Biogen’s revised research strategy is to avoid becoming obsolete, top exec says

3 months ago

RFK Jr. evades questions on vaccines and autism in written responses to senators

3 months ago

Roche separates CFO, informatics posts; Lilly execs land at Kailera, Neurocrine

3 months ago

Regeneron wins appeals court orders backing halt on Eylea biosimilars

3 months ago

Pharmacy middlemen lose bid to toss new Hawaii complaint

3 months ago

Sage turns down Biogen's buyout offer and will look at other options

3 months ago

Veru's drug lessens loss of lean mass in patients taking Wegovy

3 months ago

Moderna information chief to retire next month; Pharming looks to Flagship for first new CEO since 2008

4 months ago

As another Trump term gets underway, pharma advisors get comfortable with uncertainty

4 months ago

J&J reinforces Caplyta blockbuster projections, won't shelve neuro prospects

4 months ago

Updated: Biogen makes cuts across its research unit, shifting focus to ‘external opportunities’

4 months ago

J&J’s Spravato hit $1B in revenue in 2024

4 months ago

Renewed mifepristone fight will be early test of Trump’s abortion stance in his second term

4 months ago

Sage sues Biogen days after $469M buyout offer

4 months ago

First page Previous page 1 2 345 6 7 Next page Last page